Did you mean: Bandar Aljudaibi

Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission

…, R Aggarwal, A Aghemo, B Al-Judaibi… - The lancet …, 2019 - thelancet.com
Viral hepatitis is a major public health threat and a leading cause of death worldwide. Annual
mortality from viral hepatitis is similar to that of other major infectious diseases such as HIV …

Exercise in cirrhosis: translating evidence and experience to practice

…, KP Ismond, K Riess, A Duarte-Rojo, B Al-Judaibi… - Journal of …, 2018 - Elsevier
Physical inactivity, sarcopenia, and frailty are highly prevalent, independent predictors of
morbidity and mortality in patients with cirrhosis. Across a range of chronic diseases, exercise …

Extracorporeal liver support in patients with liver failure: a systematic review and meta-analysis of randomized trials

…, T Albrahim, B Albudoor, M Ismail, B Al-Judaibi… - Intensive care …, 2020 - Springer
Purpose Acute liver failure (ALF) and acute on chronic liver failure (ACLF) are associated with
significant mortality and morbidity. Extracorporeal liver support (ECLS) devices have been …

[HTML][HTML] Gastrointestinal and liver manifestations of COVID-19

…, T Peeraphatdit, M Mosli, B Al-Judaibi - Saudi Journal of …, 2020 - journals.lww.com
The novel coronavirus 2 (SARS-CoV-2) has spread worldwide. While patients typically
present with fever and symptoms of a respiratory illness, patients have also presented with …

Toward a personalized medicine approach to the management of inflammatory bowel disease

…, RB Kim, R Khanna, B Al-Judaibi… - Official journal of the …, 2014 - journals.lww.com
The medical management of inflammatory bowel disease (IBD) is evolving toward a
personalized medicine-based model. Modern therapeutic algorithms that feature use of tumor …

[HTML][HTML] Position statement on the diagnosis and management of non-alcoholic fatty liver disease

KA Alswat, HI Fallatah, B Al-Judaibi… - Saudi Medical …, 2019 - ncbi.nlm.nih.gov
Non-alcoholic fatty liver disease (NAFLD) is a major national and international health burden.
It is one of the most common liver diseases worldwide and the most common cause of …

[HTML][HTML] Advances in the diagnosis and management of inflammatory bowel disease: challenges and uncertainties

M Mosli, M Al Beshir, B Al-Judaibi… - Saudi Journal of …, 2014 - journals.lww.com
Over the past two decades, several advances have been made in the management of patients
with inflammatory bowel disease (IBD) from both evaluative and therapeutic perspectives. …

[HTML][HTML] The Saudi Critical Care Society practice guidelines on the management of COVID-19 in the ICU: therapy section

…, HA Alserehi, M Al-Yahya, B Al-Judaibi… - Journal of Infection and …, 2022 - Elsevier
Background The rapid increase in coronavirus disease 2019 (COVID-19) cases during the
subsequent waves in Saudi Arabia and other countries prompted the Saudi Critical Care …

Apixaban and rosuvastatin pharmacokinetics in nonalcoholic fatty liver disease

…, C Zhu, M Liu, UI Schwarz, RB Kim, B Al-Judaibi… - Drug Metabolism and …, 2018 - ASPET
There is little known about the impact of nonalcoholic fatty liver disease (NAFLD) on drug
metabolism and transport. We examined the pharmacokinetics of oral apixaban (2.5 mg) and …

Exercise training for liver transplant candidates

B Al-Judaibi, I Alqalami, M Sey, K Qumosani… - Transplantation …, 2019 - Elsevier
Background and Aims Frailty is associated with increased morbidity and mortality, and this
is tightly linked to liver decompensation and increased complication rates among liver …
Did you mean to search for: Bandar Aljudaibi